Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.
Altabás-González I, Rua-Figueroa I, Mouriño C, Roberts K, Jimenez N, Martinez-Barrio J, Galindo M, Calvo Alén J, Pérez VDC, Uriarte Itzazelaia E, Tomero E, Freire-González M, Martínez Taboada V, Salgado E, Vela P, Fernandez-Nebro A, Olivé A, Narváez J, Menor-Almagro R, Soler GS, Hernández-Beriain JÁ, Manero J, Aurrecoechea E, Ibarguengoitia-Barrena O, Montilla C, Bonilla G, Torrente-Segarra V, Cacheda AP, García-Villanueva MJ, Moriano-Morales C, Manteca CF, Lozano-Rivas N, Bohórquez C, Pego-Reigosa JM. Altabás-González I, et al. Among authors: narvaez j. Lupus Sci Med. 2024 Aug 3;11(2):e001064. doi: 10.1136/lupus-2023-001064. Lupus Sci Med. 2024. PMID: 39097409 Free PMC article.
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ].
Martín Mola E, Hernández B, García-Arias M, Alvaro-Gracia JM, Balsa A, Reino JG, Marenco de la Fuente JL, Martínez-Taboada V, Ivorra JA, Sanmartí R; el grupo de Expertos en Rituximab. Martín Mola E, et al. Reumatol Clin. 2011 Jan-Feb;7(1):30-44. doi: 10.1016/j.reuma.2010.11.002. Epub 2010 Dec 17. Reumatol Clin. 2011. PMID: 21794777 Free article. Spanish.
The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB).
Fernández-Nebro A, Marenco JL, López-Longo F, Galindo M, Hernández-Cruz BE, Narváez J, Rúa-Figueroa I, Raya-Alvarez E, Zea A, Freire M, Sánchez-Atrio AI, García-Vicuña R, Pego-Reigosa JM, Manrique-Arija S, Nieves-Martín L, Carreño L; LESIMAB GROUP. Fernández-Nebro A, et al. Among authors: narvaez j. Lupus. 2014 Sep;23(10):1014-22. doi: 10.1177/0961203314534909. Epub 2014 May 15. Lupus. 2014. PMID: 24833667
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.
Altabás-González I, Pego-Reigosa JM, Mouriño C, Jiménez N, Hernández-Martín A, Casafont-Solé I, Font Urguelles J, Román-Ivorra JA, de la Rubia Navarro M, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blázquez-Cañamero MÁ, Marras C, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo-Alén J, de Dios JR, Álvarez Rodríguez B, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Rúa-Figueroa IJ. Altabás-González I, et al. Among authors: narvaez j. Rheumatology (Oxford). 2025 Jan 1;64(1):276-282. doi: 10.1093/rheumatology/kead696. Rheumatology (Oxford). 2025. PMID: 38490245 Free PMC article.
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.
Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Salvarani C, González-Gay MA, Martín J, Sawalha AH; Spanish GCA Study Group; Italian GCA Study Group; Turkish Takayasu Study Group; Vasculitis Clinical Research Consortium. Carmona FD, et al. Sci Rep. 2017 Mar 9;7:43953. doi: 10.1038/srep43953. Sci Rep. 2017. PMID: 28277489 Free PMC article.
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry.
Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Martín JS, Narváez J, Calvo I, Mendizábal J, Alcázar LA, Loricera J, Roman AR, Moya P, Tortosa-Cabañas M, Estrada P, Prado FJ, Castañeda S, Blanco R. Molina-Collada J, et al. Among authors: narvaez j. Rheumatology (Oxford). 2024 Jan 20:keae042. doi: 10.1093/rheumatology/keae042. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38244610
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis.
Martín-Gutiérrez A, Loricera J, Narváez J, Aldasoro V, Maiz O, Vela P, Romero-Yuste S, de Miguel E, Galíndez-Agirregoikoa E, Fernández-López JC, Ferraz-Amaro I, Sánchez-Martín J, Moya P, Campos C, López-Gutiérrez F, Castañeda S, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Martín-Gutiérrez A, et al. Among authors: narvaez j. Eur J Intern Med. 2024 Nov;129:78-86. doi: 10.1016/j.ejim.2024.06.013. Epub 2024 Jun 22. Eur J Intern Med. 2024. PMID: 38908981
Sustained Drug-Free Remission in Giant Cell Arteritis.
Narváez J, Domínguez M, Agirregoikoa EG, Mendizábal J, Abasolo L, Lluch J, Loricera J, Garrido N, Castañeda S, Alvarado PM, Larena C, Estrada P, Galisteo C, Riveros Frutos A, Ortiz Sanjuán F, Salman T, Vasques Rocha M, Iñiguez CL, González MG, Blanco R; ARTESER Project Collaborative Group. Narváez J, et al. Rheumatology (Oxford). 2024 Nov 26:keae644. doi: 10.1093/rheumatology/keae644. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39589919
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford CA, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Daikeler T, Berger CT, Molloy ES, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel PA, Cid MC, González-Gay MA, Morgan AW, Martin J, Márquez A; Spanish GCA Group; UK GCA Consortium; Vasculitis Clinical Research Consortium. Borrego-Yaniz G, et al. Lancet Rheumatol. 2024 Jun;6(6):e374-e383. doi: 10.1016/S2665-9913(24)00064-X. Epub 2024 May 8. Lancet Rheumatol. 2024. PMID: 38734017 Free PMC article.
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.
Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Salvarani C, González-Gay MA, Martín J, Sawalha AH; Spanish GCA Study Group; Italian GCA Study Group; Turkish Takayasu Study Group; Vasculitis Clinical Research Consortium. Carmona FD, et al. Sci Rep. 2017 Apr 5;7:46012. doi: 10.1038/srep46012. Sci Rep. 2017. PMID: 28378796 Free PMC article. No abstract available.
554 results